Michael Santoro

« Back to Faculty Directory
Professor
Office Location: 
100 Rock: Room 2151
Office Phone: 
848-445-5756
Academic Info
Education: 

Ph.D., Harvard University; Public Policy

Expertise: 

Human Rights, Ethical Leadership, Wall Street, Business Ethics, Corporate Governance, Pharmaceutical Industry Ethics, Intellectual Property, and Corporate Social Responsibility in China.

Teaches: 

Business Govt. & Society; Ethics in Business; Ethics, Business, & Society; Law & Legal Reasoning

Michael A. Santoro is a world renowned business ethics teacher, scholar and consultant. He is a Professor of Management and Global Business at Rutgers Business School.  He holds a Ph.D. in Public Policy from Harvard University, a J.D. from New York University, and an A.B. from Oberlin College.

Prof. Santoro has served as a consultant to the Global Business Coalition on HIV/AIDS, Malaria, and Tuberculosis, helping in that capacity to design an industry-wide corporate integrity  program for companies supplying long lasting anti-malaria bednets.  He also worked with Arusha-based A to Z Corporation to design, adopt and implement one of the first business ethics code of conduct in Tanzania.  His expert testimony in the Vioxx litigation became the basis for court-ordered corporate governance reforms adopted by Merck.

He has been a visiting Professor at the Shanghai Advanced Institute of Finance and the University of Zurich, as well as an Adjunct Lecturer and a Teaching Fellow at Harvard’s John F. Kennedy School of Government where he taught ethics and economics courses.  As a Research Associate at Harvard Business School, he wrote or co-authored nearly thirty case studies and teaching notes on ethical and legal topics, including a leading case on the introduction of intellectual property into the WTO. He was an invited speaker at the American Bar Association Conference on Professionalism in the 21st Century.  He was the recipient of research grant from the Aspen Institute’s Initiative for Social Innovation through Business and he has also served as a GE Teaching Fellow at Rutgers Business School.

He serves on the Editorial Board of Business Ethics Quarterly and the Journal of Human Rights, and he is a member of the Board of Directors of the NASBA Center for the Public Trust.

Professor Santoro testified before the United States Senate Finance Committee on the human rights implications of China’s entry into the World Trade Organization.  He is a frequent featured speaker on human rights and business ethics at numerous venues, including Cornell, Columbia, Oberlin, Princeton, Redlands, Santa Clara, and Tufts , as well as at the Brookings Institution, the World Affairs Council, the Economic Strategy Institute, the Association of the Bar of the City of New York, and the Asia Society.

Prof. Santoro was a Fulbright Fellow at the University of Hong Kong during the 1993-94 academic year and he travels frequently to Asia.  In the summer, he has taught executive MBA courses in Business Strategy and Business Law in Beijing and Shanghai and at the Sinopec Management Institute.

Prior to entering academe, Santoro practiced law.  During law school he was a clerk at Skadden Arps Slate Meagher & Flom.  He was summer associate at Shearman & Sterling and an associate at Webster & Sheffield.  He has been the General Counsel of BioTechnica International in Cambridge, Massachusetts, one of the first publicly-held biotechnology companies, and of Finevest (now Interlaken Capital) in Greenwich, Connecticut, a privately held venture firm.

 

Faculty Insights

Rutgers Business School News

Faculty Insight: Professor Michael Santoro raises questions about Merck's continued marketing of NuvaRing

Wednesday, February 5, 2014

In an article for Medical Marketing and Media, Professor Santoro notes the role pharmaceutical companies have in society. "They make profits by serving patients. This role comes with many special ethical responsibilities," he writes. "One is to continually innovate safety as well as efficacy. Another is to share, not hide, scientific and medical truth with doctors and patients. Neither of these ethical responsibilities ought to be delineated by craftily drawn legal lines."  More ›

TAGS: Ethics Faculty Insights MBA Merck Michael Santoro

Rutgers Business School News

Faculty Insight: Can a disgraced trader get a job in academia?

Wednesday, January 22, 2014

Rutgers Business School Professor Michael Santoro, who teaches ethics in business, spent part of last summer observing the federal court trial of former Goldman Sachs trader Fabrice Tourre. In a new article written for The New Yorker, Santoro contemplates the possibility that Tourre, who is working on a doctorate degree, could land a job teaching at a business school.  More ›

TAGS: Banking Ethics Faculty Insights Michael Santoro Rutgers Business School Wall Street

Rutgers Business School News

Faculty Insight: It may be time for Johnson & Johnson to challenge its credo...again

Tuesday, December 3, 2013

In an article published in Medical Marketing & Media, Rutgers Business School Professor Michael Santoro suggests that it may be time for Johnson & Johnson executives to challenge their credo, a statement the company says guides its decision making. "Is the Credo today a living, breathing set of values and beliefs that inspire and guide the actions of Johnson & Johnson employees or is it a set of fine sounding platitudes carved into stone that are no longer relevant to the way J&J manages and makes decisions?" Santoro writes in the piece. More ›

TAGS: Ethics Faculty Insights Johnson and Johnson Michael Santoro

Rutgers Business School News

Faculty Insight: Michael Santoro blog on SEC v Tourre trial picked up by The New Yorker

Wednesday, July 24, 2013

Rutgers Business School Professor Michael Santoro, a widely quoted expert on Wall Street ethics, is spending summer break studying Wall Street – and its regulators – at the federal court trial of former Goldman Sachs trader Fabrice Tourre. Now his blog has been picked up by The New Yorker. More ›

TAGS: Blogs Ethics Expertise Faculty Insights Management and Global Business Michael Santoro Thought Leadership Twitter Wall Street

Rutgers Business School News

Faculty Insight: Michael Santoro espouses SEC intention to require banks to admit guilt in enforcement actions

Thursday, July 18, 2013

The public is tired of checkbook justice in which Wall Street has been able to write off seemingly huge settlements as a mildly irritating cost of doing business. Earlier this month, Professor Michael Santoro, Department of Management and Global Business, and Professor Ronald Strauss, Montclair State University School of Business, blogged in the Huffington Post about the SEC stopping its long-standing practice of settling enforcement actions in a way that allows defendants to avoid either admitting or denying guilt.  More ›

TAGS: Faculty Insights Management and Global Business Michael Santoro